{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:39:07Z","timestamp":1777635547100,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.prro.2021.12.008","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T20:30:45Z","timestamp":1640377845000},"page":"e207-e215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of Specific Duodenal Dose Constraints During Treatment Planning Reduces Toxicity After Definitive Paraaortic Radiation Therapy for Cervical Cancer"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8866-1003","authenticated-orcid":false,"given":"David S.","family":"Lakomy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana V.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqian Henry","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Jhingran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Eifel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilie L.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2021.12.008_bib0001","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/IGC.0000000000000177","article-title":"Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: A review","volume":"24","author":"Smits","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2021.12.008_bib0002","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0360-3016(98)00267-3","article-title":"Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A gynecologic oncology group study","volume":"42","author":"Varia","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0003","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.prro.2016.09.003","article-title":"Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy","volume":"7","author":"Osborne","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3325\/cmj.2010.51.229","article-title":"Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: Prospective study","volume":"51","author":"Du","year":"2010","journal-title":"Croat Med J"},{"key":"10.1016\/j.prro.2021.12.008_bib0005","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","article-title":"Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose\u2013positron emission tomography simulation in patients with locally advanced cervical cancer","volume":"77","author":"Kidd","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0006","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2013.09.053","article-title":"Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer","volume":"88","author":"Verma","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.prro.2021.12.008_bib0008","doi-asserted-by":"crossref","first-page":"os20","DOI":"10.1093\/jicru\/os20.1.20","article-title":"Report 38","author":"Chassagne","year":"1985","journal-title":"J ICRU"},{"key":"10.1016\/j.prro.2021.12.008_bib0009","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0010","first-page":"333","article-title":"Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix","volume":"49","author":"Wharton","year":"1977","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prro.2021.12.008_bib0011","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0090-8258(80)90039-6","article-title":"Extended field irradiation for invasive carcinoma of the cervix","volume":"9","author":"Cheung","year":"1980","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0012","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9378(81)90519-6","article-title":"Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma","volume":"139","author":"Piver","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.prro.2021.12.008_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0090-8258(84)90151-3","article-title":"Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes","volume":"19","author":"Berman","year":"1984","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0014","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ijrobp.2007.01.026","article-title":"Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116","volume":"68","author":"Small","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0360-3016(98)00132-1","article-title":"Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10","volume":"41","author":"Grigsby","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0016","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.meddos.2013.02.004","article-title":"Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer","volume":"38","author":"Pair","year":"2013","journal-title":"Med Dosim"},{"key":"10.1016\/j.prro.2021.12.008_bib0017","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2006.12.023","article-title":"Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer","volume":"68","author":"Beriwal","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0018","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/IGC.0b013e3182643b7c","article-title":"Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution","volume":"22","author":"Zhang","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2021.12.008_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00520","article-title":"Long-term survival and late toxicity associated with pelvic intensity modulated radiation therapy (IMRT) for cervical cancer involving CT-based positive lymph nodes","volume":"9","author":"Lei","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0020","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ijrobp.2012.10.004","article-title":"Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes","volume":"85","author":"Poorvu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13014-014-0320-5","article-title":"Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis","volume":"10","author":"Yoon","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1748-717X-9-83","article-title":"IMRT with (1)(8)FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer","volume":"9","author":"Cihoric","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3802\/jgo.2014.25.1.14","article-title":"Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer","volume":"25","author":"Zhang","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183339","article-title":"Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose","volume":"12","author":"Kwak","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prro.2021.12.008_bib0025","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2018.11.012","article-title":"Intensity modulated radiation therapy and image-guided adapted brachytherapy for cervix cancer","volume":"103","author":"Lin","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0026","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.prro.2014.10.013","article-title":"Extended field intensity modulated radiation therapy for gynecologic cancers: Is the risk of duodenal toxicity high?","volume":"5","author":"Xu","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0027","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.09.075","article-title":"A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer","volume":"78","author":"Murphy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0028","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/j.ijrobp.2012.06.005","article-title":"Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies","volume":"84","author":"Bae","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0029","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.ijrobp.2012.09.035","article-title":"Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer","volume":"85","author":"Kelly","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0030","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group Trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0402-z","volume":"10","author":"Marnitz","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2021.12.008_bib0032","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/acm2.12003","article-title":"Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients","volume":"18","author":"Deng","year":"2017","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0033","doi-asserted-by":"crossref","first-page":"675","DOI":"10.21037\/atm.2019.10.53","article-title":"A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy vs. 9-field intensity-modulated radiation therapy","volume":"7","author":"Wu","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.prro.2021.12.008_bib0034","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jmrs.311","article-title":"The role of volumetric modulated arc therapy (VMAT) in gynaecological radiation therapy: A dosimetric comparison of intensity modulated radiation therapy versus VMAT","volume":"66","author":"Knapp","year":"2019","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.prro.2021.12.008_bib0035","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/0360-3016(95)00118-I","article-title":"Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix","volume":"32","author":"Eifel","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.12.008_bib0036","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2040622313510730","article-title":"Radiation-induced small bowel disease: Latest developments and clinical guidance","volume":"5","author":"Stacey","year":"2014","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850021003519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850021003519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:24:47Z","timestamp":1761819887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850021003519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1879850021003519"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2021.12.008","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Specific Duodenal Dose Constraints During Treatment Planning Reduces Toxicity After Definitive Paraaortic Radiation Therapy for Cervical Cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}